Nipocalimab
Nipocalimab is a pharmaceutical drug with 21 clinical trials. Currently 11 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
8
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
11
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
Clinical Trials (21)
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women
Nipocalimab in Moderate to Severe Sjogren's Disease
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants
A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants
A Study of Nipocalimab in Healthy Male and Female Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21